Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-08

Clinical Trial Update: Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder [NA]

View source ↗

Summary

A clinical trial update investigating the use of artificial intelligence applied to molecular imaging to predict Parkinson's disease risk in individuals with RE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Parkinson Disease, REM Sleep Behavior Disorder | NA | Status: RECRUITING